Literature DB >> 20466481

Transformation of intracranial anaplastic astrocytoma associated with neurofibromatosis type I into gliosarcoma: case report.

Jin-Hwan Cheong1, Choong-Hyun Kim, Jae-Min Kim, Young-Ha Oh.   

Abstract

Gliosarcoma is an uncommon malignant brain tumor composed of distinct sarcomatous and malignant glial cell elements. These tumors are defined as a variant of glioblastoma, and it can be developed by progression of the malignant glial cell tumors or primary tumors. We report a rare case with gliosarcomatous recurrence of anaplastic astrocytoma with neurofibromatosis type 1 (NF-1) followed by chemoradiation therapy. A 26-year-old male patient was presented with headache. Five years before admission, he had been diagnosed with NF-1. Magnetic resonance imaging (MRI) showed a well-demarcated, enhanced lesion in the right frontal lobe and multiple enhanced lesions in the scalp, lower cervical, thoracic, and upper lumbar regions. He underwent an osteoplastic craniotomy with total tumor resection. Histopathology of the tumor showed findings corresponding with anaplastic astrocytoma. He was followed by radiotherapy and chemotherapy postoperatively. A month later, his spinal lesion was also resected and confirmed pathologically as plexiform neurofibroma. The subsequent follow-up period of 27 months was uneventful until he developed a generalized tonic-clonic seizure. MRI showed tumor recurrence in the original site of the tumor. Re-exploration was carried out. Pathological examination displayed a biphasic pattern of the glial and sarcomatous components suggesting gliosarcoma. (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20466481     DOI: 10.1016/j.clineuro.2010.04.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  4 in total

1.  Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab.

Authors:  Brett J Theeler; Benjamin Ellezam; Shlomit Yust-Katz; John M Slopis; Monica E Loghin; John F de Groot
Journal:  J Neurol       Date:  2014-05-25       Impact factor: 4.849

2.  Epilepsy in NF1: a systematic review of the literature.

Authors:  Pia Bernardo; Giuseppe Cinalli; Claudia Santoro
Journal:  Childs Nerv Syst       Date:  2020-07-01       Impact factor: 1.475

3.  Secondary gliosarcoma after the treatment of primary glioblastoma multiforme.

Authors:  Khalid Andaloussi-Saghir; Mohamed Oukabli; Mohammed El Marjany; Hassan Sifat; Khalid Hadadi; Hamid Mansouri
Journal:  N Am J Med Sci       Date:  2011-11

4.  Adjuvant Radiation Therapy and Temozolomide in Gliosarcoma: Is It Enough? Case Series of Seven Patients.

Authors:  Himanshu Srivastava; Abhinav Dewan; Surender Kumar Sharma; Preety Negi; Ajay Kumar Dewan; Sunil Pasricha; Krati Mehrotra
Journal:  Asian J Neurosurg       Date:  2018 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.